Anti-M is a relatively common naturally occurring antibody reacting optimally at 4°C and weakly or nonreactive at 37°C. It is usually clinically insignificant but can be active at 37°C because of thermal amplitude of IgM component or presence of IgG component. It can cause or delayed hemolytic transfusion reactions or hemolytic disease of newborn. At our center we have encountered two cases of anti-M antibodies-one presenting as crossmatch incompatibility and other as blood grouping discrepancy in the last 8 months.
Introduction Introduction
In adults, anti-M is a relatively common naturally occurring antibody reacting optimally at 4°C and weakly or nonreactive at 37°C. [1] It is usually clinically insignificant but can be active rarely at 37°C because of thermal amplitude of IgM component or presence of IgG component. It can cause or delayed hemolytic transfusion reactions or hemolytic disease of newborn. At our center we have encountered two cases of anti-M antibodies one presenting as crossmatch incompatibility and other as blood grouping discrepancy in the last 8 months.
Case Reports Case Reports Case 1 Case 1
Demand for two units of packed red blood cells (PRBC) came to our blood bank for a 20-year-old female (G 2 P 1 A 0 L 1 ) at 36 weeks of pregnancy. Her hemoglobin was 7.0 g/dl. The blood group of the patient was 'A' Rh 'D' +ve. However, all donor red cell units were incompatible by Indirect Antiglobulin Test (IAT) with both, gel technique (-ID Microtyping system) and conventional test tube method. The sample was referred to the Immunohematology lab (IHL) for workup. Direct antiglobulin test (DAT) was performed on patient's red cells using polyspecifi c antiglobulin reagents (anti IgG and C3d) and found negative along with negative autocontrol. Case 2 Case 2 A 22-year-old female, G5P2A2L0 at 28 weeks of pregnancy, Rh isoimmunized, to be taken up for intrauterine transfusion (IUT). Cell grouping of patient was AB negative while reverse (serum) grouping showed agglutination with A and B cells. To solve this ABO discrepancy IHL workup was done. Patient's DAT and autocontrol were negative. Antibody screening using three-cell panels gave a differential of anti-D, anti-k, anti-Kpb, anti-Jsb, anti-M, anti-Lub, anti-Fya, anti-Jka, and anti-P1 [ Figure 3 ]. Antibody was identifi ed using 11-cell panels as anti-M [ Figure 4 ].
It was confi rmed by repeating the reverse grouping with M-antigen negative A and B cells and no reaction was seen. Specifi city of the antibody was determined as IgM after treatment with DTT. Although this antibody was clinically insignifi cant yet M-antigen negative 'O' Rh 'D'-ve unit, which was crossmatch compatible with the patient was issued. Successful IUT was performed.
Discussion Discussion
Anti-M antibodies are usually naturally occurring, cold reactive, and clinically insignifi cant antibodies. Anti-M is common in antenatal patients (even when the fetus is M-negative); however, there are few reports of potent IgG anti-M that is active at 37°C and causes HDFN. [1] This holds true for our fi rst case. Although the anti-M antibody had IgG component which was reactive at 37°C it was not potent enough to cause HDN in the fetus. However, such anti-M is capable of causing acute or delayed hemolytic reaction in the recipient (mother). [2] Anti-M is generally thought of as an IgM cold-reacting antibody; however, most anti-M antibodies appear to be IgG or have an IgG component. [3] Anti-M, whether IgM or IgG, does not bind complement. Anti-M antibodies that react at colder temperatures (i.e., room temperature and 4°C) and dissociate at 37°C or in AHG phase of antibody testing, generally are not considered clinically signifi cant. [4] Incidence of 'M' antigen is fairly common in the population, about 75% (worldwide). [2] Incidence of anti-M in donor sera was found to be 1 In 2500 when reacting with homozygous M+N-cells while incidence reduced to half i.e., 1 in 5000 when screened with heterozygous M+N+ cells, indicating that some weaker examples of anti-M may be missed with heterozygous cells. [5] In our fi rst patient there was stronger reaction with homozygous cells as compared to heterozygous M+N+ cells. MN antibodies are often pH dependent. IgM anti-M has an optimum pH of 6.5 and are mostly inactive at pH 7.5, becoming non-specifi c below pH 6.5. [5] Another feature of this antibody is its failure to react with fi cin or papain-premodifi ed cells. Proteolytic enzymes, such as fi cin or papain, cleave red cell membrane sialoglycoproteins at well-defi ned sites. [6] Cases of clinically significant anti-M antibodies have been reported by Tandon et al., and Justin et al. [4, 6] Moreover 15 cases of patients with auto anti-M have been reported and reviewed by Sacher et al., [7] According to him, 11 were non-signifi cant while rest four gave some symptoms of cold hemagglutinin disease. A few cases of warm autoimmune hemolytic anemia (AIHA) caused by autoanti-N have been described, one of which had fatal outcome. However, autoanti-M, responsible for warm AIHA, has not been reported [2, 5] . Anti-M causing HDN has been reported by Duguid J et al., Kanra T et al., Furukawa K et al., [8] [9] [10] ranging from cases requiring exchange transfusions to intrauterine fetal deaths.
It is important to type specificity of anti-M antibody with accuracy as it can infl uence clinical outcome. Reactions can be falsely interpreted as positive in AHG phase if a high titer IgMtype antibody reacts at room temperature and agglutination is carried forward to AHG phase. Therefore strict warm conditions should be maintained during incubation and centrifugation; there should be no interruption during the procedure and results should be read immediately.
Although clinically signifi cant anti-M antibodies are rare, once encountered, antigen-negative blood should be issued to prevent inadvertent adverse effects of transfusion. 
